Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine.

Grigg AP, Reynolds J, McQuillan A, Juneja SK, Di Iulio J, Hui C, Smith C, Kimber R, Bradstock KF, Australasian Leukaemia and Lymphoma Group

Open source

DOI
10.1080/10428190400013076
Published
2005 Mar
Container
Leukemia & lymphoma
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/10428190400013076,
  title = {Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine.},
  author = {Grigg AP and Reynolds J and McQuillan A and Juneja SK and Di Iulio J and Hui C and Smith C and Kimber R and Bradstock KF and Australasian Leukaemia and Lymphoma Group},
  year = {2005},
  journal = {Leukemia \& lymphoma},
  doi = {10.1080/10428190400013076},
  url = {https://doi.org/10.1080/10428190400013076}
}

RIS

TY  - JOUR
TI  - Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine.
AU  - Grigg AP
AU  - Reynolds J
AU  - McQuillan A
AU  - Juneja SK
AU  - Di Iulio J
AU  - Hui C
AU  - Smith C
AU  - Kimber R
AU  - Bradstock KF
AU  - Australasian Leukaemia and Lymphoma Group
PY  - 2005
JO  - Leukemia & lymphoma
DO  - 10.1080/10428190400013076
UR  - https://doi.org/10.1080/10428190400013076
ER  - 

APA

AP, G., J, R., A, M., SK, J., J, D. I., C, H., C, S., R, K., KF, B., & Group, A. L. A. L. (2005). Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine.. Leukemia & lymphoma. https://doi.org/10.1080/10428190400013076

Source records